Summit Therapeutics PLC (SMMT) — Cash Flow-to-Debt Ratio
Summit Therapeutics PLC (SMMT) has a Cash Flow-to-Debt Ratio of -1.37x as of June 2026, meaning its operating cash flow of $-167.78 Million could theoretically repay -1% of its total liabilities ($122.20 Million) in one year. See how financially flexible is Summit Therapeutics PLC to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Summit Therapeutics PLC Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Summit Therapeutics PLC across 23 annual periods. For the full cash flow conversion analysis, see how efficiently does Summit Therapeutics PLC generate cash.
Annual Cash Flow-to-Debt Ratio for Summit Therapeutics PLC (2003–2025)
Year-by-year debt coverage analysis for Summit Therapeutics PLC. Check Summit Therapeutics PLC earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.50x | $-239.67 Million | $68.52 Million | ▼ -15.2% |
| 2024 | -3.04x | $-113.56 Million | $37.41 Million | ▼ -395.4% |
| 2023 | -0.61x | $-60.74 Million | $99.12 Million | ▼ -692.2% |
| 2022 | -0.08x | $-33.90 Million | $438.18 Million | ▲ +96.8% |
| 2021 | -2.41x | $-53.81 Million | $22.30 Million | ▼ -15.5% |
| 2020 | -2.09x | $-35.34 Million | $16.93 Million | ▼ -12.3% |
| 2019 | -1.86x | $-26.66 Million | $14.34 Million | ▼ -25.7% |
| 2018 | -1.48x | $-35.11 Million | $23.74 Million | ▼ -348.4% |
| 2017 | -0.33x | $-20.58 Million | $62.40 Million | ▼ -211.6% |
| 2016 | 0.30x | $15.18 Million | $51.35 Million | ▲ +106.8% |
| 2015 | -4.36x | $-24.47 Million | $5.62 Million | ▼ -154.7% |
| 2014 | -1.71x | $-16.59 Million | $9.69 Million | ▲ +26.2% |
| 2013 | -2.32x | $-9.68 Million | $4.18 Million | ▼ -10.9% |
| 2012 | -2.09x | $-5.03 Million | $2.41 Million | ▼ -28.5% |
| 2011 | -1.62x | $-3.80 Million | $2.34 Million | ▲ +16.2% |
| 2010 | -1.94x | $-4.34 Million | $2.24 Million | ▼ -277.8% |
| 2009 | -0.51x | $-2.65 Million | $5.15 Million | ▲ +72.9% |
| 2008 | -1.90x | $-14.72 Million | $7.77 Million | ▼ -79.8% |
| 2007 | -1.05x | $-16.13 Million | $15.30 Million | ▼ -11.9% |
| 2006 | -0.94x | $-5.96 Million | $6.33 Million | ▼ -151.8% |
| 2005 | -0.37x | $-931.84K | $2.49 Million | ▼ -540.3% |
| 2004 | 0.08x | $29.74K | $350.21K | ▲ +100.5% |
| 2003 | -17.81x | $-64.97K | $3.65K | — |